Register Your Interest
Register your interest in the course. When we schedule dates, we will be in touch.
Master the scientific, regulatory, and strategic complexities of cell therapy development to accelerate progress from bench to bedside – Click Here to Download the Agenda
Register your interest in the course. When we schedule dates, we will be in touch.
Learn more about the course by toggling through the tabs below. Scroll down to view the agenda, trainer info and who should attend.
The field of cell therapy holds transformative potential for treating a wide range of diseases. However, it also presents unique and complex challenges that can hinder the development and commercialisation of these innovative therapies. The course Mastering Development and Regulatory Challenges in Cell Therapy is designed to equip biotech and pharmaceutical professionals with the in-depth knowledge and strategic insights needed to navigate the complexities of developing cell-based therapies.
By the end of this course, participants will have gained a comprehensive understanding of cell therapy and how to address the key challenges in developing cell-based therapeutics. They will be equipped to make strategic decisions that improve the probability of success, reduce risks, and support the effective development of complex cell therapy approaches.
Find out when this course is running so you can plan your training. Scroll down to view the full agenda.
2-Day Live Online Training
Register at the top of the page.
If you want to train a small group, we offer a group discount between 5% and 50% depending on the course and number of attendees.
For a quote, complete our contact form by following the link. Get in touch.
We also design and deliver fully customised team training focused on your products, processes, technologies and challenges. This is ideal for specific training requirements or larger groups. Please get in touch with us for more information.
For more information, complete our contact form by following the link. Get in touch.
Learn more about the course by toggling through the tabs below (trainer, agenda, who should attend?)
Course Information
Introduction to Cell Therapy Development
Pharmacology Challenges in Cell Therapy
Preclinical to Clinical Translation
CMC and Scale-Up Challenges
Regulatory Considerations for Cell Therapies
Leveraging Differentiation and Competitive Intelligence
Strategic Insights for Successful Development
Case Studies and Emerging Trends
Gareth is an experienced biopharmaceutical R&D professional, drug hunter and global project lead with 10+ years of leadership in project/program management, portfolio governance and scientific strategy. He has a successful record of progressing complex, multi-million-dollar drug development programs through internal and external initiatives. He has furthered his practical experience in both Europe and the US, in clinical, pharmaceutical, VC and academic environments facilitating the preclinical -> clinical transition of novel medicinal products. Relevant former roles and institutions include Principal Investigator/Lecturer (Harvard Medical School & Boston Children’s Hospital), Fellow and Project Lead (Vertex Pharmaceuticals), Global Project Lead (Boehringer-Ingelheim) and Asset and Scientific Evolution Lead (invoX Pharma).
In his current role(s), he leads a dynamic cross-functional global team that pushes scientific and drug development boundaries, developing novel medicinal products and drug-device combinations (modality and indication agnostic), to meet unmet patient needs worldwide. He has a wealth of experience in establishing agile governance frameworks to oversee a diverse clinical and preclinical portfolio. Notably, he has extensive experience in translational biomarker strategies, indication expansions (repurposing), and effective tech-transfer for up-scale bioprocessing of biologics.
Overseeing a global team, Gareth has a proven track record in increasing pipeline visibility and executing external collaborations. He has bridged the gap between preclinical -> clinical, implementing novel ‘first-4-patient’ initiatives, such as 5’R research frameworks, relevant clinical biomarker strategies and optimising human dose prediction models to enhance the probability of success of medicinal products.
This course is designed for professionals involved in the development, manufacturing, and regulation of cell-based therapies, including those in R&D, clinical development, regulatory affairs, quality assurance, manufacturing, and business development within small biotech and large pharmaceuticals.
It is also beneficial for senior executives who want to improve their understanding of the development process to improve commercial decision-making.
Discount has been applied to the price above. VAT, if applicable, will be added.
You can view the agenda below or if you would like to receive a pdf version with all the course information, please complete the form below.
Reviews
There are no reviews yet.